Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation

Blood

Volumn 90, Issue 1, 1997, Pages 194-203

  Williams, Catherine D ^a   Linch, David C ^a   Watts, Mike J ^a   Thomas, N Shaun B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0031007609     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.194     Document Type: Article

References (40)

1. Gianni AM, Bregni M, Stern AC, Siena S, Tarella C, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2:580, 1989
2. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
3. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A, Borkett K: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353, 1996
4. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD: Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1:1194, 1988
5. Roberts AW, Metcalf D: Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol 22:1156, 1994
6. Roberts AW, Metcalf D: Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 86:1600, 1995
7. + cells. Blood 84:2930, 1994
8. + cells in cord blood and in cytokine-mobilized blood. Br J Haematol 92:255, 1996
9. Ponchio L, Conneally E, Eaves C: Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood 86:3314, 1995
10. Jordan CT, Yamasaki G, Minamoto D: High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 24:1347, 1996
11. La Thangue NB: DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci 19:108, 1994
12. Bandara LR, Buck VM, Zamanian M, Johnston LH, La Thangue NB: Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J 12:4317, 1993
13. Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E: Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 7:1850, 1993
14. Helin K, Harlow E, Fattaey A: Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501, 1993
15. Moberg K, Starz MA, Lees JA: E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 16:1436, 1996
16. Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees JA: In vivo association of E2F and DP family proteins. Mol Cell Biol 15:2536, 1995
17. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053, 1991
18. Weintraub SJ, Prater CA, Dean DC: Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259, 1992
19. Duronio RJ, O'Farrell PH, Xie JE, Brook A, Dyson N: The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev 9:1445, 1995
20. Dobrowolski SF, Stacey DW, Harter ML, Stine JT, Hiebert SW: An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene 9:2605, 1994
21. Sardet C, Vidai M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA: E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 92:2403, 1995
22. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T: The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157, 1992
23. Johnson DG, Schwarz JK, Cress WD, Nevins JR: Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349, 1993
24. Lukas J, Petersen BO, Holm K, Bartek J, Helin K: Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 16:1047, 1996
25. Vairo G, Livingston DM, Ginsberg D: Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev 9:869, 1995
26. Chittenden T, Livingston DM, DeCaprio JA: Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol Cell Biol 13:3975, 1993
27. Williams CD, Linch DC, Sorensen TS, La Thangue NB, Thomas NSB: The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4, DP-1 and p 130. Br J Haematol 96:688, 1997
28. Watts MJ, Jones HM, Sullivan AM, Langabeer SE, Jamieson E, Fielding A, Williams C, Berenson RJ, Goldstone AH, Linch DC: Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. Br J Haematol 91:767, 1995
29. Jones HM, Lodge MS, Fogarty BL, Beringer RW, Tarnowski SJ: Epitope mapping CD34 monoclonals using an immobilised peptide array, in Kishimoto T, Kikutani H (eds): Leukocyte Typing VI. New York, NY, Garland (in press)
30. Burke LC, Bybee A, Thomas NS: The retinoblastoma protein is partially phosphorylated during early G1 in cycling cells but not in G1 cells arrested with alpha-interferon. Oncogene 7:783, 1992
31. Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB: A new component of the transcription factor DRTF1/E2F. Nature 362:83, 1993
32. Mayol X, Garriga J, Grana X: G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13:237, 1996
33. Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710, 1984
34. Bruno S, Darzynkiewicz Z: Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 25:31, 1992
35. Zetterberg A: Cell growth and cell cycle progression in mammalian cells, in Thomas NSB (ed): Apoptosis and Cell Cycle Control in Cancer. Oxford, UK, Scientific Publishers, 1996, p 17
36. + cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant 14:827, 1994
37. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
38. Beijersbergen RL, Carlee L, Kerkhoven RM, Bernards R: Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev 9:1340, 1995
39. Suzuki Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S. Okuyama A: The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10:1691, 1995
40. Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR: The accumulation of an E2F-p 130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol 16:6965, 1996